# Laser photobiomodulation enhances cell viability and regenerative gene expression in oxidative-stressed muscle cells

**Authors:** Ana Flávia Spadaccini Silva-de-Oliveira, Jéssica Lúcio da Silva, Nathalia Thalitha Bernardes dos Santos, Rodrigo Antonio Carvalho Andraus, Regina Célia Poli-Frederico, Deise Aparecida de Almeida Pires Oliveira, Rodrigo Franco de Oliveira, Luciana Prado Maia

PMC · DOI: 10.1007/s10103-026-04811-w · 2026-02-05

## TL;DR

Laser therapy protects muscle cells from stress and boosts genes linked to muscle repair.

## Contribution

The study shows LPT can protect muscle cells and enhance regenerative gene expression under oxidative stress.

## Key findings

- LPT at specific wavelengths and fluences increased cell viability beyond control levels.
- LPT upregulated MyoD and myogenin genes, which are important for muscle regeneration.
- IL-6 expression was detected under specific LPT conditions in both PRE- and POST-OS groups.

## Abstract

This study aimed to evaluate the effects of laser photobiomodulation therapy (LPT) on muscle cells subjected to oxidative stress. The primary objective was to determine whether LPT could preserve cell viability and modulate the expression of genes associated with muscle regeneration, specifically MyoD and myogenin, as well as the pro-inflammatory cytokine IL-6. Methods: C2C12 myoblasts were cultured and exposed to oxidative stress using hydrogen peroxide (H₂O₂) at a concentration of 50 µM for 1 h. Cells were then irradiated with LPT at wavelengths of 660–808 nm with fluences of 3, 5, and 10 J, applied either before (PRE-OS) or after (POST-OS) oxidative stress induction. Cell viability was assessed by the MTT assay, and gene expression was quantified using RT-qPCR. Results: Oxidative stress significantly reduced cell viability. LPT applied prior to OS with 660 nm (3 J) and 808 nm (3 and 10 J) attenuated this reduction. Notably, 10 J at 808 nm (PRE-OS) increased viability beyond control levels and markedly upregulated MyoD expression. Myogenin expression was also observed under 10 J PRE-OS conditions, while IL-6 expression was detected with 5 J at both wavelengths in PRE- and POST-OS groups. Conclusion: LPT demonstrated protective and regenerative effects on myoblasts under oxidative stress, preserving viability and enhancing regenerative gene expression. These findings support the potential of LPT as a therapeutic strategy for muscle injuries and disorders associated with oxidative stress.

## Linked entities

- **Genes:** MYOD1 (myogenic differentiation 1) [NCBI Gene 4654], myog.S (myogenin S homeolog) [NCBI Gene 373806], IL6 (interleukin 6) [NCBI Gene 3569]
- **Chemicals:** hydrogen peroxide (PubChem CID 784)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 280826], glyceraldehyde-3-phosphate dehydrogenase [NCBI Gene 786101], LOC517016 (interleukin 6 (interferon, beta 2)) [NCBI Gene 517016] {aka IF1DA6}, MYOD1 (myogenic differentiation 1) [NCBI Gene 281938] {aka MyoD}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 509965] {aka CK, CMPK}, COX6A1 (cytochrome c oxidase subunit 6A1) [NCBI Gene 282199] {aka VIA L}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 281181] {aka GAPD}, MYOD1 (myogenic differentiation 1) [NCBI Gene 4654] {aka CMYO17, CMYP17, MYF3, MYOD, MYODRIF, PUM}, MYOG (myogenin) [NCBI Gene 281343], MYOG (myogenin) [NCBI Gene 4656] {aka MYF4, bHLHc3, myf-4}
- **Diseases:** contusions (MESH:D003288), injuries (MESH:D014947), ischemia (MESH:D007511), necrosis (MESH:D009336), inflammation (MESH:D007249), impaired regeneration (MESH:D060825), OS (MESH:D000079225), neurodegenerative diseases (MESH:D019636), musculoskeletal conditions (MESH:D009140), lacerations (MESH:D022125), fatigue (MESH:D005221), muscle damage (MESH:D009133), Muscle injuries (MESH:D009135)
- **Chemicals:** DMSO (MESH:D004121), tetrazolium (MESH:D013778), ROS (MESH:D017382), CO2 (MESH:D002245), H2O (MESH:D014867), H2O2 (MESH:D006861), DMEM (-), PRE (MESH:D004656), RNS (MESH:D026361)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** J774 — Mus musculus (Mouse), Mouse reticulum cell sarcoma, Cancer cell line (CVCL_4692), C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12872728/full.md

---
Source: https://tomesphere.com/paper/PMC12872728